NASA NTRSDate not supplied
BACKGROUND As NASA’s mission programs begin to shift from Low Earth Orbit (LEO) to planetary mission profiles, the importance of understanding the phenomena a human experience when returning from spaceflight is of increased importance. The purpose of this study was to assess trends across individuals in the symptoms experienced during the landing process of long duration ISS missions. METHODS Data for this study is an aggregation of mission level data from forms used by crew surgeons at R+0, electronic medical records, notes from weekly Space Medicine Operation Team meetings, records in the Shuttle Mission Data Archive, and data collected by research teams in the Human Research Program (HRP). Aggregated data was used in descriptive analysis of the trends in medical events and countermeasure use. The data was also used to identify high value targets for emphasis in on going surveillance efforts. RESULTS Completeness of reporting varied greatly over time and across missions dependent on information sources available for data extraction. Landing forms provided the most complete data but still missed or left unconfirmed, several, common symptoms, and countermeasures. Data aggregation did show to cover gaps within individual data sources. Commonly reported symptoms included nystagmus, vertigo, and nausea. Common protocols for fluid loading and meclizine are reflected within the data set. DISCUSSION The data set generated in this project provides a foundation that show how symptoms of astronauts as they return to Earth varies across the long duration ISS missions. While there is an abundance of information provided within the data set, there are still inconsistencies in reporting especially in the absence of the landing day form. Further data collection practices should be standardized to ease the burden on crew surgeons during R+0 exams and better collect high value variables.